GRI Bio, Inc. received a deficiency letter from Nasdaq stating that it did not comply with the minimum stockholders equity requirement for continued listing.
AI Assistant
GRI BIO INC
2024
8 K
Find Answers
Ask about any part of the document to get insights, explanations, or key details.